Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 8, 2014, Pages 2942-2947

  Voigt, Julia ^a   Christensen, Jon ^a   Shastri, V Prasad ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Aromatic polysulfonates; Polyanion; Polystyrene sulfonate; Vasculature

Indexed keywords

CAVEOLIN; POLYANION; POLYELECTROLYTE; SOLID LIPID NANOPARTICLE; SULFONIC ACID DERIVATIVE;

ARTICLE; BINDING AFFINITY; CAVEOLA; CELL SURFACE; CHEMICAL STRUCTURE; ENDOCYTOSIS; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; LIPOPHILICITY; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNTHESIS; UPREGULATION;

AROMATIC POLYSULFONATES; POLYANION; POLYSTYRENE SULFONATE; VASCULATURE;

ANIMALS; BLOTTING, WESTERN; CAVEOLAE; CELL LINE; CHEMICAL ENGINEERING; DRUG DELIVERY SYSTEMS; ELECTROLYTES; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; NEOPLASMS; POLYMERS; REAL-TIME POLYMERASE CHAIN REACTION; STATIC ELECTRICITY; SULFONIC ACIDS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84896825407     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1322356111     Document Type: Article

References (32)

1. Farokhzad OC, Langer R (2009) Impact of nanotechnology on drug delivery. ACS Nano 3(1):16-20.
2. Schroeder A, et al. (2012) Treating metastatic cancer with nanotechnology. Nat Rev Cancer 12(1):39-50.
3. Yan Y, Such GK, Johnston APR, Best JP, Caruso F (2012) Engineering particles for therapeutic delivery: Prospects and challenges. ACS Nano 6(5):3663-3669.
4. Farokhzad OC, et al. (2006) Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 103(16):6315-6320.
5. Heath TD, Fraley RT, Papahdjopoulos D (1980) Antibody targeting of liposomes: Cell specificity obtained by conjugation of F(ab')2 to vesicle surface. Science 210(4469):539-541.
6. Danhier F, et al. (2009) Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. J Control Release 140(2):166-173.
7. Neri D, Bicknell R (2005) Tumour vascular targeting. Nat Rev Cancer 5(6):436-446. (Pubitemid 40791486)
8. Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422(6927):37-44. (Pubitemid 36323287)
9. Kumari S, Mg S, Mayor S (2010) Endocytosis unplugged: multiple ways to enter the cell. Cell Res 20(3):256-275.
10. Duchardt F, Fotin-Mleczek M, Schwarz H, Fischer R, Brock R (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8(7):848-866. (Pubitemid 46971632)
11. Bareford LM, Swaan PW (2007) Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59(8):748-758. (Pubitemid 47320813)
12. Torchilin VP (2008) Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers 90(5):604-610.
13. Verma A, Stellacci F (2010) Effect of surface properties on nanoparticle-cell interactions. Small 6(1):12-21.
14. Jiang X, et al. (2010) Specific effects of surface amines on polystyrene nanoparticles in their interactions with mesenchymal stem cells. Biomacromolecules 11(3):748-753.
15. Decuzzi P, Pasqualini R, Arap W, Ferrari M (2009) Intravascular delivery of particulate systems: Does geometry really matter? Pharm Res 26(1):235-243.
16. Champion JA, Mitragotri S (2006) Role of target geometry in phagocytosis. Proc Natl Acad Sci USA 103(13):4930-4934.
17. Saha K, et al. (2013) Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells. Small 9(2):300-305.
18. Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L (2005) Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 23(11):1418-1423. (Pubitemid 41679395)
19. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C (2007) Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev 59(6):454-477. (Pubitemid 47259226)
20. Schneider J, et al. (2013) Surface functionality as a means to impact polymer nanoparticle size and structure. Langmuir 29(12):4092-4095.
21. Razani B, Woodman SE, Lisanti MP (2002) Caveolae: From cell biology to animal physiology. Pharmacol Rev 54(3):431-467.
22. Cohen AW, Hnasko R, Schubert W, Lisanti MP (2004) Role of caveolae and caveolins in health and disease. Physiol Rev 84(4):1341-1379. (Pubitemid 39287953)
23. Heikkilä O, et al. (2010) Internalization of coxsackievirus A9 is mediated by beta2-microglobulin, dynamin, and Arf6 but not by caveolin-1 or clathrin. J Virol 84(7):3666-3681.
24. Beloqui A, et al. (2013) Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J Control Release 166(2):115-123.
25. Schnitzer JE, Oh P, Pinney E, Allard J (1994) Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 127(5):1217-1232. (Pubitemid 24362558)
26. Torgersen ML, Skretting G, van Deurs B, Sandvig K (2001) Internalization of cholera toxin by different endocytic mechanisms. J Cell Sci 114(Pt 20):3737-3747. (Pubitemid 33041055)
27. Jacobson K, Mouritsen OG, Anderson RGW (2007) Lipid rafts: At a crossroad between cell biology and physics. Nat Cell Biol 9(1):7-14. (Pubitemid 46024188)
28. Schnitzer JE (2001) Caveolae: From basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev 49(3):265-280.
29. Watson M, Abbott KC, Yuan CM (2010) Damned if you do, damned if you don't: Potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol 5(10):1723-1726.
30. Sterns RH, Rojas M, Bernstein P, Chennupati S (2010) Ion-exchange resins for the treatment of hyperkalemia: Are they safe and effective? J Am Soc Nephrol 21(5):733-735.
31. Chrastina A, Massey KA, Schnitzer JE (2011) Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3(4):421-437.
32. Campbell SM, Crowe SM, Mak J (2001) Lipid rafts and HIV-1: From viral entry to assembly of progeny virions. J Clin Virol 22(3):217-227. (Pubitemid 32846552)